Patients intent upon beginning the Marshall Protocol should familiarize themselves with the various resources and Knowledge Base articles available to the them including:
Important: The Autoimmunity Research Foundation does not support or license the public use of this therapy by patients not actively participating on the MarshallProtocol.com and/or CureMyTh1.org sites.
There are currently three online forums for patients interested in learning more about the Marshall Protocol. Patients are asked to use the same username and password at each site of which they are members.
| Marshall Protocol Study Site | Cure My Th1 (Disease) | |
| URL | http://marshallprotocol.com/ | http://curemyth1.org/ |
| Topics | symptom reports, science | |
| Moderated by | patient advocates; Trevor Marshall, PhD | patient advocates |
| Registration/posting | membership granted via application process | open to all |
| Access (patients) | To apply to join, please refer to these instructions. | open to all |
| Access (health professionals) | available upon request; health professionals are granted access to the Private Section for Health Professionals | open to all |
Before beginning the Marshall Protocol, patients are required to review the Checklist for starting the Marshall Protocol.
The Marshall Protocol (MP) is a powerful treatment plan and must be followed exactly. Every aspect of the MP is designed with a patient's safety in mind. Patients intent on beginning the MP should first ensure that they have completed all the items on the checklist before they begin.
Patients on the Marshall Protocol (MP) must work with a licensed physician or other healthcare practitioner, such as a nurse practitioner or physician's assistant. Patients who have the most successful outcomes are proactive and prepared. They internalize the requirements for the MP and, when necessary, work to address any of their physicians' concerns about the treatment. At this point, no doctors are certified in the use of the MP.
Generally speaking, it may make more sense to convince one's existing doctor before trying to find a new one. However, Autoimmunity Research Foundation maintains a list of doctors who are or have been willing to prescribe the Marshall Protocol. The list of local MP doctors is available upon request by posting at CureMyTh1.org.
Note that at this point, no doctors are certified in the use of the Marshall Protocol. For this reason, it is important that MP patients familiarize themselves with the stated guidelines.
Used in the context of the Marshall Protocol (MP), a therapeutic probe refers to a brief trial of the MP, in which patients take regular doses of olmesartan (Benicar) with pulsed, low doses of antibiotics and restrict consumption of vitamin D. The presence of a positive treatment response is taken as an indication that a patient is sick with Th1 disease and that the MP is a treatment option for that disease. Although there are other factors and variables, which can strongly suggest the presence of Th1 disease, the therapeutic probe is currently the best method for determining if the MP may be suitable for a patient.
In the context of the therapeutic probe, there are at least three responses or types of responses which indicate that continued treatment with the MP is warranted:
Symptoms which wax and wane in tandem with the every-other-day administration of antibiotics are an especially strong indication of Th1 disease.
It is expected that the way a patient responds to the MP will change over time.
Some patients who have difficulty finding a supportive doctor or have practical reasons to delay taking the MP medications want to do what they can immediately to start the healing process. Eliminating vitamin D (food and supplements) and avoiding natural or bright light exposure are measures that can be followed without a doctor's prescription and may make a patient feel better. It may also allow the immune system to begin functioning and killing bacteria, thus provoking an immune system reaction. This will cause an increase in symptoms (perhaps intolerable) and possibly an increase in inflammation to joints and organs not yet protected by olmesartan.
Withdrawing vitamin D is encouraged but patients who are not starting olmesartan yet should proceed with caution. All prospective patients, but particularly those who have not yet started olmesartan, should read about a potential withdrawal reaction from light restriction.
http://www.curemyth1.org/forum1/2725.html (How to write a sig line)